Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: A novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance

Manzour Hernando Hazbón, Miriam Bobadilla Del Valle, Marta Inírida Guerrero, Mandira Varma-Basil, Ingrid Filliol, Magali Cavatore, Roberto Colangeli, Hassan Safi, Helen Billman-Jacobe, Caroline Lavender, Janet Fyfe, Lourdes García-García, Amy Davidow, Michael Brimacombe, Clara Inés León, Tania Porras, Mridula Bose, Fernando Chaves, Kathleen D. Eisenach, José Sifuentes-OsornioAlfredo Ponce De León, M. Donald Cave, David Alland

Research output: Contribution to journalArticlepeer-review

99 Scopus citations

Abstract

Mutations at position 306 of embB (embB306) have been proposed as a marker for ethambutol resistance in Mycobacterium tuberculosis; however, recent reports of embB306 mutations in ethambutol-susceptible isolates caused us to question the biological role of this mutation. We tested 1,020 clinical M. tuberculosis isolates with different drug susceptibility patterns and of different geographical origins for associations between embB306 mutations, drug resistance patterns, and major genetic group. One hundred isolates (10%) contained a mutation in embB306; however, only 55 of these mutants were ethambutol resistant. Mutations in embB306 could not be uniquely associated with any particular type of drug resistance and were found in all three major genetic groups. A striking association was observed between these mutations and resistance to any drug (P < 0.001), and the association between embB306 mutations and resistance to increasing numbers of drugs was highly significant (P < 0.001 for trend). We examined the association between embB306 mutations and IS6110 clustering (as a proxy for transmission) among all drug-resistant isolates. Mutations in embB306 were significantly associated with clustering by univariate analysis (odds ratio, 2.44; P = 0.004). In a multivariate model that also included mutations in katG315, katG463, gyrA95, and kasA269, only mutations in embB306 (odds ratio, 2.14; P = 0.008) and katG315 (odds ratio, 1.99; P = 0.015) were found to be independently associated with clustering. In conclusion, embB306 mutations do not cause classical ethambutol resistance but may predispose M. tuberculosis isolates to the development of resistance to increasing numbers of antibiotics and may increase the ability of drug-resistant isolates to be transmitted between subjects.

Original languageEnglish (US)
Pages (from-to)3794-3802
Number of pages9
JournalAntimicrobial agents and chemotherapy
Volume49
Issue number9
DOIs
StatePublished - Sep 2005
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: A novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance'. Together they form a unique fingerprint.

Cite this